CYGB and cancer: In cancer, tumor growth is suppressed by expressing E. coli flavoHb-NOD in brain gliomas [297], overexpressing Cygb in head and neck squamous cell carcinomas [298, 299] or, paradoxically, by decreasing Mb in breast cancer cells [7].